Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013 (2013), Article ID 507270, 5 pages
http://dx.doi.org/10.1155/2013/507270
Clinical Study

Influence of Febrile Neutropenia Period on Plasma Viscosity at Malignancy

1Department of Medical Oncology, Medicana International Hospital Cancer Center, 06520 Ankara, Turkey
2Department of Hematology, Baskent University School of Medicine, 06490 Ankara, Turkey
3Department of Medical Oncology, Baskent University School of Medicine, 06490 Ankara, Turkey
4Department of Infectious Diseases and Clinical Microbiology, Baskent University School of Medicine, 06490 Ankara, Turkey

Received 19 August 2013; Accepted 12 September 2013

Academic Editors: A. Roccaro and A. Saudemont

Copyright © 2013 Ibrahim Tek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. H. Berra, E. Piaggio, S. S. Revelli, and A. Luquita, “Blood viscosity changes in experimentally Trypanosoma cruzi-infected rats,” Clinical Hemorheology and Microcirculation, vol. 32, no. 3, pp. 175–182, 2005. View at Google Scholar · View at Scopus
  2. E. Alt, B. R. Amann-Vesti, C. Madl, G. Funk, and R. Koppensteiner, “Platelet aggregation and blood rheology in severe sepsis/septic shock: relation to the Sepsis-related Organ Failure Assessment (SOFA) score,” Clinical Hemorheology and Microcirculation, vol. 30, no. 2, pp. 107–115, 2004. View at Google Scholar · View at Scopus
  3. J. de Naurois, I. Novitzky-Basso, M. J. Gill, F. M. Marti, M. H. Cullen, and F. Roila, “Management of febrile neutropenia: ESMO clinical practice guidelines,” Annals of Oncology, vol. 21, supplement 5, pp. v252–v256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Klastersky, M. Paesmans, E. B. Rubenstein et al., “The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients,” Journal of Clinical Oncology, vol. 18, no. 16, pp. 3038–3051, 2000. View at Google Scholar · View at Scopus
  5. A. Uys, B. L. Rapoport, and R. Anderson, “Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score,” Supportive Care in Cancer, vol. 12, no. 8, pp. 555–560, 2004. View at Google Scholar · View at Scopus
  6. A. G. Freifeld, E. J. Bow, K. A. Sepkowitz et al., “Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America,” Clinical Infectious Diseases, vol. 52, no. 4, pp. e56–e93, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. R. S. Rosenson, A. McCormick, and E. F. Uretz, “Distribution of blood viscosity values and biochemical correlates in healthy adults,” Clinical Chemistry, vol. 42, no. 8, part 1, pp. 1189–1195, 1996. View at Google Scholar · View at Scopus
  8. O. Yetkin, I. Tek, F. Yetkin, and N. Numanoglu, “Role of pleural viscosity in the differential diagnosis of exudative pleural effusion,” Respirology, vol. 12, no. 2, pp. 267–271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Késmárky, P. Kenyeres, M. Rábai, and K. Tóth, “Plasma viscosity: aforgotten variable,” Clinical Hemorheology and Microcirculation, vol. 39, no. 1–4, pp. 243–246, 2008. View at Google Scholar
  10. F. Yetkin, U. Kayabas, Y. Ersoy, Y. Bayindir, S. A. Toplu, and I. Tek, “Cerebrospinal fluid viscosity: a novel diagnostic measure for acute meningitis,” Southern Medical Journal, vol. 103, no. 9, pp. 892–895, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. A. Morris, H. B. Tanowitz, M. Wittner, and J. P. Bilezikian, “Pathophysiological insights into the cardiomyopathy of Chagas' disease,” Circulation, vol. 82, no. 6, pp. 1900–1909, 1990. View at Google Scholar · View at Scopus